Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
State Key Laboratory of Biotherapy and Cancer Center,
West China Hospital,
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital
Yiguo Hu has not added Biography.
If you are Yiguo Hu and would like to personalize this page please email our Author Liaison for assistance.
The bromodomain protein BRD4 positively regulates necroptosis via modulating MLKL expression.
Cell death and differentiation Oct, 2019 | Pubmed ID: 30644439
Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma.
Oncotarget Oct, 2019 | Pubmed ID: 31666930
Characterizing dedifferentiation of thyroid cancer by integrated analysis.
Science advances Jul, 2021 | Pubmed ID: 34321197
High-dose vitamin D metabolite delivery inhibits breast cancer metastasis.
Bioengineering & translational medicine Jan, 2022 | Pubmed ID: 35111955
Pancreatic tumor eradication via selective Pin1 inhibition in cancer-associated fibroblasts and T lymphocytes engagement.
Nature communications Jul, 2022 | Pubmed ID: 35879297
Sichuan University and Collaborative Innovation Center
Yuanfan Qian1,2,
Linye He1,2,
Anping Su1,2,
Yiguo Hu3,
Jingqiang Zhu1
1Thyroid and Parathyroid Surgery Center, West China Hospital of Sichuan University,
2The Laboratory of Thyroid and Parathyroid Disease, West China Hospital of Sichuan University,
3State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.